Researchers discover that bone marrow cancer cells diversify drastically when exiting the bone marrow, which also affects the ...

Throughout my experience with multiple myeloma, I was humbled by the unexpected support and kindness shown to me.

The team tackled a critical challenge in treating multiple myeloma-a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients.

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

A research team from the Heidelberg Medical Faculty, the German Cancer Research Center (DKFZ), the Berlin Institute of Health ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

Beyond oncology, these materials may have applications in non-malignant diseases involving bone degeneration or fractures. "This innovation addresses a significant unmet need in multiple myeloma ...

New innovative local treatment for osteolytic bone disease in multiple myeloma Date: January 14, 2025 Source: Vrije Universiteit Brussel Summary: A team of researchers has developed a new ...

Black Americans have double the risk of developing multiple myeloma compared to white Americans and are diagnosed at younger ages.

1 Multiple myeloma originates in blood plasma cells — a type of cell found in bone marrow that is responsible for making antibodies. When these plasma cells become cancerous, they multiply ...

Myeloma, or multiple myeloma, is a cancer affecting a ... characterized by the accumulation of abnormal plasma cells in the bone marrow, which impairs the normal production of blood cells.